In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a pHiso-Med Drug Master File in Korea (pHiso-Med KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of pHiso-Med. The MFDS reviews the pHiso-Med KDMF as part of the drug registration process and uses the information provided in the pHiso-Med KDMF to evaluate the safety and efficacy of the drug.
After submitting a pHiso-Med KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their pHiso-Med API can apply through the Korea Drug Master File (KDMF).
click here to find a list of pHiso-Med suppliers with KDMF on PharmaCompass.